Clinical Trials Directory

Trials / Completed

CompletedNCT00301353

Effects of Phytoestrogen-rich Diets on Bone Turnover in Postmenopausal Women

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
300 (planned)
Sponsor
TNO · Academic / Other
Sex
Female
Age
40 Years – 65 Years
Healthy volunteers
Accepted

Summary

Osteoporosis is a major health problem. It was hypothesized that isoflavone-containing products may be a potential alternative to HRT for preventing bone loss during the menopausal transition. We investigated whether one-year consumption of isoflavone-enriched foods affected bone mineral density, bone metabolism and hormonal status in early postmenopausal women in a randomized double-blind, placebo controlled parallel multi-centre trial.

Detailed description

Two hundred and thirty-seven healthy early post-menopausal women (age 53 ± 3 y; time since last menses 33 ± 15 months) consumed isoflavone-enriched foods providing a mean daily intake of 110 mg isoflavone aglycones or control products for 1 yr whilst continuing their habitual diet and lifestyle. Outcome measures included bone mineral density of lumbar spine and total body, markers for bone formation and bone resorption, hormones, isoflavones in plasma and urine, safety parameters and reporting of adverse events.

Conditions

Interventions

TypeNameDescription
DRUGIsoflavones-enriched foods

Timeline

Start date
2002-10-01
Completion
2004-07-01
First posted
2006-03-10
Last updated
2015-05-21

Locations

3 sites across 3 countries: France, Italy, Netherlands

Source: ClinicalTrials.gov record NCT00301353. Inclusion in this directory is not an endorsement.